© 2003 BMJ Publishing Group
ORIGINAL ARTICLE
Lung cancer mortality among chromate production workers
1 Applied Epidemiology, Inc., PO Box 2424, Amherst, Massachusetts 01004, USA
2 AMEC Earth and Environmental, Gulf Tower, 707 Grant Street, Suite 81, Pittsburgh, Pennsylvania 15219, USA
3 5307 Ravenna Place, NE, #3, Seattle, Washington 98105, USA
4 Environ, 2220 South Vienna, Ruston, Louisiana 71270, USA
5 Exponent, 320 Goddard Way, Suite 200, Irvine, California 92618, USA
Correspondence to:
Correspondence to:
Ms D M Proctor, Exponent, 320 Goddard Way, Suite 200, Irvine, CA 92618, USA;
dproctor{at}exponent.com
Aims: To assess mortality in 1997 among 493 former workers of a US chromate production plant employed for at least one year between 1940 and 1972.
Methods: Cohort members were followed for mortality to 31 December 1997. Standardised mortality ratios (SMRs) were calculated for selected cause specific categories of death including lung cancer. Lung cancer mortality was investigated further by calculation of SMRs stratified by year of hire, duration of employment, time since hire, and categories of cumulative exposure to Cr(VI).
Results: Including 51 deaths due to lung cancer, 303 deaths occurred. SMRs were significantly increased for all causes combined (SMR = 129), all cancers combined (SMR = 155), and lung cancer (SMR = 241). A trend test showed a strong relation between lung cancer mortality and cumulative hexavalent exposure. Lung cancer mortality was increased for the highest cumulative exposure categories (
1.05 to <2.70 mg/m3-years, SMR = 365;
2.70 to 23 mg/m3-years, SMR = 463), but not for the first three exposure groups. Significantly increased SMRs were also found for year of hire before 1960, 20 or more years of exposed employment, and latency of 20 or more years.
Conclusions: The finding of an increased risk of lung cancer mortality associated with Cr(VI) exposure is consistent with previous reports. Stratified analysis of lung cancer mortality by cumulative exposure suggests a possible threshold effect, as risk is significantly increased only at exposure levels over 1.05 mg/m3-years. Though a threshold is consistent with published toxicological evidence, this finding must be interpreted cautiously because the data are also consistent with a linear dose response.
Keywords: hexavalent chromium; dose-response; lung cancer
Abbreviations: CI, confidence interval; DMF, Death Master File; ICD, International Classification of Diseases; NDI-Plus, National Death Index Plus; NIOSH, National Institute for Occupational Safety and Health; SMR, standardised mortality ratio; SSN, social security number
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Russo, P., Catassi, A., Cesario, A., Imperatori, A., Rotolo, N., Fini, M., Granone, P., Dominioni, L.
(2005). Molecular Mechanisms of Hexavalent Chromium-Induced Apoptosis in Human Bronchoalveolar Cells. Am. J. Respir. Cell Mol. Bio.
33: 589-600
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
